Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

Similar documents
What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

Diabetes Medications: Oral Anti-Hyperglycemic Medications

Diabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018

RPCC Pharmacy Forum. The Type 2 Diabetes Issue. Type 2 Diabetes: The Basics

1/15/2018. Disclosures. Current Diabetes Medications. Objectives NON-INSULIN AGENTS. Diabetes Med Classes. Mealtime

DIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions. Insulins. Rapid Short Intermediate Long Mix

Oral Medication for the Management of Diabetes Mechanism of. Duration of Daily Dosing Action

Diabetes Treatment Guidelines

Clinical Pharmacotherapeutic Applications of the American Diabetes Association Standards of Care 2018

Physician Drug Reference Chart for Diabetes Antidiabetic Medications

Pharmacology Updates. Quang T Nguyen, FACP, FACE, FTOS 11/18/17

DIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents

How to Fight Diabetes and Win. Diabetes. Medications

Diabetes Management: A diagnostic perspective

TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

Non-Insulin Diabetes Medications Summary

What s New in Diabetes Medications. Jena Torpin, PharmD

TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

4/9/2018 HOW TO REGULATE DIABETES MEDICATIONS. By Sarah Froemsdorf MSN, RNC, CDE, FNP DISCLOSURES NONE. Diagnosis

Table 1. Antihyperglycemic agents for use in type 2 diabetes

FARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)

Clinical Cases in Diabetes Management. Joseph Cook D.O.

Managing Complex Diabetes Cases: Medication Update. Celia Levesque MSN, RN, CNS-BC, CDE, BC-ADM

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

Oral and Injectable Medication Options for Diabetes Treatment

Update on Diabetic Medications UMA SUNDARAM, M.D. DIABETES & ENDOCRINE ASSOCIATES APRIL 07, 2018

Diabetes Mellitus II CPG

Collaborative Practice Agreement

Diabetes Update 2018: Challenging Transitions. Patricia A. Daly, MD, FACP, FACE Medical Director for Diabetes Valley Health System

Management of Type 2 Diabetes Mellitus. Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism

Pharmacologic Agents for Treatment of Type 2 Diabetes

Diabetes Update 2018: Challenging Transitions. Patricia A. Daly, MD, FACP, FACE Medical Director for Diabetes Valley Health System

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions

Fee-for-Service Pharmacy Provider Notice #216 ** March 2016 PDL Changes ** Existing Drug Classes

I. General Considerations

Drug Therapy in Diabetes HEATHER TINGLE UK COLLEGE OF PHARMACY, PY4

Pharmacology. Kacy Aderhold, MSN, APRN-CNS, CMSRN

Antidiabetic Agents CHAPTER BIGUANIDES

Update on Therapies for Type 2 Diabetes: Angela D. Mazza, DO July 31, 2015

Jonathan Stoehr, MD PhD Endocrinology, Diabetes, Metabolism and Nutrition Virginia Mason Medical Center Seattle, WA 2012 Virginia Mason Medical

Diabetes Update Bryan Heart Conference September 5, 2015 Shannon Wakeley, MD. Disclosures. Objectives 9/1/2015

Improving Patient Outcomes with Individualized Therapy in the Management of Type 2 Diabetes

3. Cardiovascular Disease?

What s New in Diabetes Treatment. Disclosures

Drug Class Review Newer Diabetes Medications and Combinations

Healthy You: A Guide to Diabetes Self-Care SURVIVAL SKILLS

Glycemic Management of Type 2 Diabetes. Gail Nunlee-Bland, M.D. Professor Medicine & Pediatrics Director, Diabetes Treatment Center Howard University

New Therapies for Diabetes

Advanced Practice Education Associates. Endocrine

2018 Diabetes Summit Managing Diabetes: An Art and a Science

Diabetes Basics. Type 1 diabetes The body cannot make insulin Requires insulin injection Is not treated with oral diabetes medicines (pills)

INSIGHTS PRACTICE INSULIN, PRIOR AUTHORIZATION, AND UTILIZATION MANAGEMENT DECEMBER 2017 DEVELOPED BY THE AMERICAN PHARMACISTS ASSOCIATION

STEP THERAPY CRITERIA

Disclosures. Objectives 11/2/2015. Type 2 Diabetes Mellitus: Medication Update. Diabetes Recommendations. Main Pathophysiological Defects in T2DM

Understanding Your Diabetes: A Basic Guide

continuing education for pharmacists

Clinical Practice Guidelines

DM Fundamentals Class 4 Meds for Type 2

Antihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014

Diabetes 2016: Strategies for achieving optimal diabetes control

Search strategies key terms

DM Fundamentals Class 4 Meds for Type 2

Oral and Injectable Non-insulin Antihyperglycemic Agents

Very Practical Tips for Managing Type 2 Diabetes

2/17/2016. Objectives. Define. Hey Sugar! DMII Management in Hospice Care

6/1/2018. Lou Haenel, IV, DO, FACE, FACOI Endocrinology Roper St Francis Charleston, SC THE OMINOUS OCTET: HOW PATHOPHYSIOLOGY AND THERAPY MERGE

Welcome to the PHASE Learning Community! October 31, 2018

What s New in Type 2 Diabetes? 2018 Diabetes Updates

The information in this guide comes from a government-funded review of research about pills for type 2 diabetes.

Clinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures

DIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013

Initiating Injectable Therapy in Type 2 Diabetes

Drug Class Review Monograph GPI Class 27 Anti-diabetics

New Medications and Prescribing Methods for Diabetic Patients

Type 2 Diabetes Mellitus: Update on Pharmacotherapy 04/04/18

What You Should Know About Diabetes. Laura Bingell RN Transition Center Nurse for MFP (607)

Diabetes Update 10/12/2017. Section #1 OBJECTIVE. Lab features to consider:

How they work and when to take them. Diabetes Medications

ORAL AND INJECTABLE (NON-INSULIN) PHARMACOLOGICAL AGENTS FOR TYPE 2 DIABETES

Deaths Hospitalizations Company. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Janssen Pharmaceuticals

Report Writing Specifications

DIABETES RESEARCH A CLINICIAN S OVERVIEW

The Community Pharmacist s Role in Diabetes Treatment

Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Type II Diabetes Improving Blood Sugar Control. Geneva Clark Briggs, Pharm.D., BCPS

Remote attendees, please mute your phones as a courtesy thank you!

What s New in Type 2 Diabetes? 2018 Diabetes Updates

Glucagon-Like Peptide (GLP-1) Receptor Agonists Clinical Edit Criteria

Caring for Your Diabetes:

Victoza (Liraglutide) Solution for Injection

ORAL AGENTS OLD & NEW FOR THE MANAGEMENT OF T2DM

Management of Type 2 Diabetes Mellitus

Date of Review: September 2016 Date of Last Review: September 2015

Staying Healthy With Diabetes

The Death of Sulfonylureas? A Review of New Diabetes Medications

Disclosures. Objectives. Bryan Cardiology Conference DM2 & Cardiovascular Outcome Trials 8/28/2017

*Jeremiah 33:6 *'Nevertheless, I will bring health and healing to it; I will heal my people and will let them enjoy abundant peace and security.

Comparison of GLP-1 Agonists

Transcription:

How Medicine Works to Control Blood Sugar Levels Stacie Petersen, RN, CDE Objectives Define Diabetes List how medications work (ominous octet) Identify side effects of medications for diabetes What is diabetes? Diabetes is a group of diseases characterized by high blood glucose levels that result from defects in the body's ability to produce and/or use insulin What Happens When We Eat? Normal Blood Glucose Control High Blood Glucose (Hyperglycemia) 1

Types of diabetes Type 1-Beta cells in pancreas that produce insulin are destroyed Requires insulin to survive 5-10% of population Type 2-Pancreas not utilizing insulin properly Lack of insulin production Insufficient insulin action (resistant cells) 90-95% of population *Beta Cells eventually wear out What is the best medicine to manage your diabetes? LIFESTYLE CHANGES Lifestyle Changes Weight loss Decrease weight by 5-7% (if overweight) Exercise 30 minutes 5 days a week Ominous Octet Diabetes Prevention Program (DPP) results: Lifestyle changes can reduce chance of diabetes by 58% Biguanides Metformin Glucophage, Fortamet, Riomet, Glucophage XR Decreases release of sugar from the liver Increases absorption of sugar into the muscle Take with food to help side effects Side Effects: Diarrhea, upset stomach Sulfonylureas Glynase, Diabeta, Glucotrol, Amaryl, Diabinese Glyburide, Micronase, Glipizide, Glimepiride, Chlorpropamide Tells pancreas to make more insulin Take before meals Side Effects: Low blood sugar 2

Meglitinides Alpha Glucosidase Inhibitors Prandin (Repaglinide) Starlix (Nateglinide) Tells pancreas to make insulin quickly Take with each meal Short acting Side Effects: Low blood sugar Precose (Acarbise) Glyset (Miglitol) Slows down absorption of carbohydrates in the gut Take with meals Side Effects: Gas Thiazolidinediones (TZD s) Actos (Pioglitazone) Avandia (Rosiglitazone) Makes cells more sensitive to insulin Decreases release of sugar from the liver Side effects: Swelling, Weight Gain Dipeptidyl Peptidase-4 Inhibitor (DPP-4 Inhibitor) Januvia, Tradjenta, Onglyza, Galvus, Nesina Sitagliptin, Linagliptin, Saxagliptin, Vildagliptin, Alogliptin Blocks DPP-4 enzyme which breaks down incretins As a result keeps higher levels of incretins which Tells pancreas to make more insulin Decreases release of sugar from the liver Slows down absorption of carbohydrates in the gut Side Effects: Upper respiratory infections, stomach upset, diarrhea Sodium Glucose Cotransporter-2 (SGLT-2 Inhibitor) Invokana, Farxiga, Jardiance Canagliflozin, Dapagliflozin, Empagliflozin Kidneys normally reabsorb sugar SGLT-2 blocks reabsorption of sugar and increases excretion through urine Side Effects: Yeast infections, Urinary tract infections, Weight loss, Decrease blood pressure 3

Combination Medications Glucovance (Glyburide/Metformin) Metaglip (Glipizide/Metformin) Advandamet (Avandia/Metformin) Actoplusmet (Actos/Metformin) Avandaryl (Avandia/Amaryl) Duetact (Actos/Glimepiride) Prandimet (Prandin/Metformin) Janumet (Januvia/Metformin) Janumet XR (Januvia/Metformin XR) Jentadueto (Tradjenta/Metformin) Kombiglyze XR (Onglyza/Metformin XR) **Combination medications have same side effects as medications taken alone but they are added together. Combination Medications Kazano (Nesina/Metformin) Oseni (Nesina/Actos) Glyxambi (Tradjenta/Jardiance) Invokamet (Invokana/Metformin) Synjardy (Jardiance/Metformin) XigduoXR (Farxiga/Metformin) **Combination medications have same side effects as medications taken alone but they are added together. Glucagon-like peptide-1 (GLP-1) Byetta, Victoza, Bydureon, Trulicity, Tanzeum Exenatide, Liraglutide, Exenatide, Dulaglutide, Albiglutide **Coming 2017 Adlyxin (Lixisenatide) Body naturally produces this hormone People with diabetes do not make enough of it Replaces GLP-1 not being made by the body Enhances use of GLP-1 which helps body use insulin GLP-1 continued Tells pancreas to make more insulin Decreases release of sugar from the liver Slows down absorption of carbohydrates in the gut Tells brain you are full Side Effects: Nausea, Decrease appetite, Weight loss When do I need insulin? Diabetes medications only work as long as the body produces some of its own insulin Every person is different with regards to medication/insulin plan Insulin Hormone has to be injected or inhaled Six classes of insulin Ultra Long Acting Toujeo, Tresiba Long Acting Lantus, Levemir Intermediate Acting NPH Short Acting Regular Rapid Acting Humalog, Novolog, Apidra Very Rapid Acting-Afrezza (Inhaled version) Side Effect: Low Blood Sugar, Bruising at site 4

Ultra-Long Acting Insulin Tresiba U-100 or U-200 (Degludec), Toujeo U-300 (glargine) Background insulin Meets needs of body/organs when not eating Provides coverage well beyond 24 hours Tresiba U-200/and Toujeo less volume Take once a day/option if high doses of insulin Do not mix with other insulins Long Acting Insulin Levemir U-100 (Detemir), Lantus U-100 (Glargine) **Coming December 2016 Basaglar U-100 (Glargine) Background insulin Meets needs of body/organs when not eating Designed to last 24 hours Take once a day at same time Not compatible with other insulins Intermediate Acting NPH (Humulin N, Novolin N) Background and mealtime coverage Works 12-16 hours Usually taken twice a day Cloudy Need to mix thoroughly Can mix with Regular insulin Short Acting Regular (Humulin R, Novolin R) Mealtime insulin Lasts 5 to 6 hours Take 30 minutes before meals Rapid Acting Humalog U-100 (Lispro), Novolog U-100 (Aspart), Apidra U-100 (Glulisine) Mealtime insulin Works 2-4 hours Take 5-15 minutes before a meal Can use these in insulin pumps Rapid Acting (continued) Humalog U-200 Less Volume Delivers same dose in half the liquid Only comes in a pen which contains 600 units Designed for people on high doses of mealtime insulin (more than 25 units a meal) 5

Combination Insulins 70/30 70% NPH (intermediate acting) and 30% Regular (short acting) 75/25 MIX with Lispro Humalog Mix 75% longer acting and 25% rapid acting 50/50 MIX with Lispro Humalog Mix 50% longer acting and 50% rapid acting 70/30 with Aspart Novolog Mix 70% longer acting and 30% rapid acting Ryzodeg 70/30 (70% Tresiba and 30% Novolog) Very Rapid Acting Afrezza-only inhaled insulin available Mealtime insulin Works 2 ½-3 hours Take no more than 15 minutes before a meal Comes in cartridges Requires lung testing annually Avoid if chronic lung conditions, smoker, lung cancer Insulin tips Majority insulin pens stable 28 days in use Mixed insulin pens stable 14 days/vials 28 days in use **Check insert/ask pharmacist/health-care provider Insulin in use can be at room temperature Insulin not in use must be refrigerated Available in vials or pens Low blood sugar biggest side effect of taking insulin QUESTIONS??? 6